Physician profile
Rafael Solis
NPI 1144262270
$8,413.52
in general payments reported to CMS, 2019-2025
18 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $462 · 2021: $643 · 2022: $4,765 · 2023: $787 · 2024: $663 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,828.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,191.78 | 2019-2025 | Mavyret, Creon, Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $602.57 | 2021-2024 | Zeposia |
| Intercept Pharmaceuticals, INC. | $340.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $243.71 | 2023-2024 | Saphnelo |
| Gilead Sciences, INC. | $179.80 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $171.26 | 2019-2024 | Stelara |
| Pfizer Pharmaceuticals LLC | $109.14 | 2019 | |
| Boston Scientific Corporation | $105.14 | 2023 | Spyglass Discover |
| Janssen Biotech, INC. | $99.00 | 2020 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $91.02 | 2024-2025 | Omvoh |
| Ferring Pharmaceuticals INC. | $75.65 | 2019 | |
| Olympus Latin America, INC. | $70.58 | 2021 | |
| Exact Sciences Corporation | $46.53 | 2024-2025 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $27.78 | 2025 | Rezdiffra |
| Chiesi USA, INC. | $19.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.01 | 2021 | |
| Pbg Puerto Rico LLC | $14.44 | 2019 | |
| Pfizer INC. | $7.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.